The Use of Sun Protection After Hamam (Turkish Bath)

August 8, 2017 updated by: Stina Öberg, Herlev and Gentofte Hospital

The Use of Sun Protection After Hamam (Turkish Bath): a Randomized, Controlled, Blinded Trial

Hamam is a common spa treatment. During a Hamam, some of the outermost layer of the skin is removed. The investigators believe that partly removing a protective skin layer might increase the risk of sun burn, especially for skin that has not been exposed to sun for a long time.

The aim with this study is to assess if Hamam-treated skin is more susceptible to sun burn compared with untreated skin.

Study Overview

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Herlev, Denmark, 2730
        • Herlev and Gentofte Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ≥18 years
  • Healthy volunteers
  • Skin types 1,2,3- Fitzpatrick scale
  • Provided informed consent

Exclusion Criteria:

  • Regular medication for a condition/disease
  • Active skin disease
  • Sun exposure on the back within four weeks prior to the start of the study
  • History of premalignant or malignant skin lesions
  • Tattoo covering more than half of the back

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Hamam treated skin and sun exposure
Hamam is a skin treatment (soaping and scrubbing).
OTHER: Untreated skin and sun exposure
Skin that will not receive Hamam.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skin erythema
Time Frame: Baseline until 24 hours after sun exposure.
Change in skin erythema: comparison of Hamam treated skin with untreated skin. Photographs of the skin will be assessed by computer analysis.
Baseline until 24 hours after sun exposure.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skin erythema
Time Frame: Baseline until 24 hours after sun exposure.
Measured by a visual scale.
Baseline until 24 hours after sun exposure.
Pain
Time Frame: Baseline until 24 hours after sun exposure.
Measured by a visual analogue scale.
Baseline until 24 hours after sun exposure.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stina Öberg, MD, University of Copenhagen, Herlev Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 12, 2017

Primary Completion (ACTUAL)

May 14, 2017

Study Completion (ACTUAL)

May 14, 2017

Study Registration Dates

First Submitted

May 11, 2017

First Submitted That Met QC Criteria

May 11, 2017

First Posted (ACTUAL)

May 12, 2017

Study Record Updates

Last Update Posted (ACTUAL)

August 9, 2017

Last Update Submitted That Met QC Criteria

August 8, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • Herlev and Gentofte Hospital

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on No Medical Condition

Clinical Trials on Hamam treated skin and sun exposure

3
Subscribe